[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"chronic-kidney-disease-patients\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:chronic-kidney-disease-patients":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,39],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":38},"100577798","lipid-profile-in-diabetic-and-non-diabetic-ckd-patients-100577798",false,"NCT06802978","Lipid Profile in Diabetic and Non Diabetic CKD Patients","Study of Lipid Profile in Diabetic and Non Diabetic Chronic Kidney Disease Patients in Sohag University Hospital","CKD","Inclusion Criteria:\n\n* Patients of chronic kidney disease (CKD) presenting to the Sohag University Hospital\n* Patients aged above 20 years of age.\n* All patients who have given consent for enrolling into the study.\n\nExclusion Criteria:\n\n* Patients aged 20 years of age or below.\n* Patients on lipid-lowering drugs.\n* Kidney transplanted patients.","ALL","21 Years",{"count":20,"type":21},200,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to compare blood lipid (fat) levels in participants with chronic kidney disease (CKD) with diabetes and without diabetes and who over 20 years old.\n\nThe main question this study aims to answer is:\n\nDoes having diabetes make fat problems worse in people with chronic kidney disease (CKD), or is there no connection between them?\n\nResearchers will compare the blood lipid (fat) levels in people with chronic kidney disease (CKD) who have diabetes and those without diabetes to see if having diabetes makes lipid problems worse in CKD patients, or if there is no connection between diabetes and changes in lipid levels.\n\nParticipants will need to fast for 10 hours before undergoing this test. This means not eating any food or drinking anything except water.\n\nSamples will be taken and sent to laboratory immediately.",[25],"Chronic Kidney Disease Patients","RECRUITING","2026-06-23",{"date":29,"type":30},"2026-06-26","ACTUAL",{"date":32,"type":30},"2025-02-01",{"date":34,"type":21},"2026-06",{"name":36,"class":37},"Sohag University","OTHER",1,{"id":40,"slug":41,"hasResults":11,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":45,"eligibilityCriteria":46,"healthyVolunteers":47,"sex":17,"minAge":48,"maxAge":4,"enrollmentInfo":49,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":51,"conditions":52,"keywords":53,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":38},"100626599","glycocalyx-and-oxidative-stress-in-endothelial-function-part-1-100626599","NCT07437729","Glycocalyx and Oxidative Stress in Endothelial Function (Part 1)","The Role of Glycocalyx and Oxidative Stress in Endothelial Function (Part 1)","GlikoOxEND","Inclusion Criteria:\n\n* patients with CKD of hypertensive etiology (grades 1-2 and 3-5; eGFR CKD-EPI GFR ≥ 90 ml\u002Fmin\u002F1.73 m², i.e. \\\u003C 60 mL\u002Fmin\u002F1.73 m2), non-diabetics, non-smokers\n* patients with hypertension (according to ESH2023 Guidelines) without kidney damage (eGFR CKD-EPI \\>90 mL\u002Fmin\u002F1.73 m2) non-diabetics, non-smokers\n* healthy volunteer subjects as controls\n\nExclusion Criteria:\n\n* kidney disease of any other etiology except hypertension\n* endocrine, autoimmune or inflammatory diseases that could affect kidney function.\n* smoking\n* diabetes",true,"18 Years",{"count":50,"type":21},105,"The primary research objective of the project is to determine the role of eGC in microvascular reactivity in CKD (cross-sectional study 1).\n\nThe main objective of the project is to increase the excellence and interdisciplinarity of scientific work at MEFOS by connecting researchers from different scientific fields, improving conditions and resources for scientific work, and increasing international cooperation, in line with strategic objective 1: raising scientific excellence. The results of the project could provide pathophysiological insight into the development and maintenance of endothelial dysfunction in CKD, as well as identify new biomarkers for CKD.",[25],[54,55,56,57,58,59],"Glycocalyx","Microcirculation","Endothelium","Inflammation","Oxidative Stress","Renal Insufficiency, Chronic","2026-02-26",{"date":62,"type":30},"2026-03-02",{"date":64,"type":30},"2025-10-01",{"date":66,"type":21},"2029-09-30",{"name":68,"class":37},"Josip Juraj Strossmayer University of Osijek"]